TSE:DTC Stock Latest News
PremiumCompany AnnouncementsDefence Therapeutics Secures $3.9 Million to Boost Biotech Initiatives Defence Therapeutics Expands Market Engagement at J.P. Morgan Healthcare Conference Defence Therapeutics Strengthens Patent Portfolio, Secures Market Exclusivity PremiumCompany AnnouncementsDefence Therapeutics Welcomes New CSO to Drive Growth Defence Therapeutics Launches Convertible Debenture Offering Defence Therapeutics Welcomes Radiopharmaceutical Expert PremiumCompany AnnouncementsDefence Therapeutics Advances in Melanoma Treatment Trials Defence Therapeutics’ AccuTOX Enhances Cancer Treatment Defence Therapeutics’ Vaccine Shows Promising Results